Cassady Wealth & Retirement Planning LLC Buys 4,281 Shares of SPDR S&P Biotech ETF $XBI

Cassady Wealth & Retirement Planning LLC grew its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,141 shares of the exchange traded fund’s stock after purchasing an additional 4,281 shares during the quarter. SPDR S&P Biotech ETF comprises about 1.4% of Cassady Wealth & Retirement Planning LLC’s portfolio, making the stock its 29th biggest holding. Cassady Wealth & Retirement Planning LLC’s holdings in SPDR S&P Biotech ETF were worth $2,776,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the stock. Avoro Capital Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at $256,053,000. Wells Fargo & Company MN raised its position in SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after acquiring an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp raised its position in SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after acquiring an additional 1,187,907 shares in the last quarter. Morgan Stanley lifted its stake in SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after acquiring an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. lifted its stake in SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after acquiring an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $147.91 on Thursday. The firm has a 50-day moving average of $145.48 and a 200-day moving average of $134.07. SPDR S&P Biotech ETF has a one year low of $84.39 and a one year high of $165.71. The company has a market cap of $9.73 billion, a PE ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.